## Lipoic acid / S ligands The arsenic(III) dithiolate [PhAs(HlipS 2 )] (1, HlipS 2Ϫ 2 = re-inhibit enzymes that contain lipoic acid as a cofactor. X-ray structure analysis shows that 1 is a 2,4-disubstituted 1,3,2-duced rac-lipoic acid) has been obtained via three different routes: (A) from (PhAs
“Inhibition” of the Enzyme Model TpPh,MeZn–OH by Diketo Compounds
✍ Scribed by Teame Tekeste; Heinrich Vahrenkamp
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 144 KB
- Volume
- 2006
- Category
- Article
- ISSN
- 1434-1948
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
In order to gain a structural understanding of zinc enzyme inhibition, the model complex Tp^Ph,Me^Zn–OH was treated with various diketo compounds. α‐Keto carboxylic acids were attached to the zinc ion as anionic O,O‐chelate ligands, of which benzoylformate was oxidatively decarboxylated in air to form the benzoate complex. Two functionalized β‐diketones did not use their functionality in forming the β‐diketonate complexes. Of the α‐diketones, 2,3‐pentanedione formed the α‐keto enolate complex, while 1‐phenyl‐1,2‐propanedione underwent oxidative C–C coupling resulting in a red dinuclear bis(α‐keto enolato) complex. Of the diaryl‐α‐diketones, benzil did not react, but pyridil underwent hydrolytic cleavage to pyridine‐2‐carbaldehyde and picolinate, of which the latter was bound to the zinc ion as an N,O‐chelate ligand.(© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2006)
📜 SIMILAR VOLUMES
Application of molecular modeling approaches has potential to contribute to rational drug design. These approaches may be especially useful when attempting to elucidate the structural features associated with novel drug targets. In this study, molecular docking and molecular dynamics were applied to